You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Abiraterone Acetate

Showing 51 - 75 of 1,207
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Prostate Carcinoma, Metastatic Prostate Cancer Trial (Olaparib tablet, Abiraterone acetate, Prednisone tablet)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Olaparib tablet
  • +2 more
  • (no location specified)
Dec 7, 2021

Prostate Cancer Trial in La Jolla, Boston, New York (Apalutamide, Leuprolide, Prednisone)

Active, not recruiting
Has Results
  • Prostate Cancer
  • La Jolla, California
  • +3 more
Sep 1, 2021

Healthy Volunteers Trial in Qingdao (Abiraterone acetate tablets(Zecke ®250 mg);Abiraterone acetate tablets(250 mg))

Completed
  • Healthy Volunteers
  • Abiraterone acetate tablets(Zecke ®250 mg);Abiraterone acetate tablets(250 mg)
  • Qingdao, Shangdong, China
    Phase I Clinical Research Center
Apr 26, 2021

Prostatic Tumors, Castration-Resistant Trial in Leiden (Patient-specific adaptive therapy, Abiraterone acetate, Enzalutamide)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Patient-specific adaptive therapy
  • +2 more
  • Camperdown, New South Wales, Australia
  • +6 more
Jan 11, 2023

Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)

Active, not recruiting
Has Results
  • Prostatic Neoplasms
  • Phoenix, Arizona
  • +183 more
Jan 17, 2023

Metastatic Castration Resistant Prostate Cancer Trial in Shanghai (Fluzoparib, Enzalutamide OR abiraterone acetate With

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 23, 2022

Prostate Cancer Trial in Evanston, New York, Portland (Ipilimumab)

Active, not recruiting
  • Prostate Cancer
  • Evanston, Illinois
  • +2 more
Sep 9, 2021

NSCLC Harboring NRG1 Fusion, Metastatic Castration-resistant Prostate Cancer Trial in Whittier, Lake Mary (Afatinib Oral Tablet,

Recruiting
  • NSCLC Harboring NRG1 Fusion
  • Metastatic Castration-resistant Prostate Cancer
  • Afatinib Oral Tablet
  • +3 more
  • Whittier, California
  • +1 more
Dec 20, 2022

Prostate Cancer Trial in Vancouver, Toronto (Apalutamide 60mg Tab, Abiraterone Acetate 250mg, Prednisone 5mg Tab)

Recruiting
  • Prostate Cancer
  • Apalutamide 60mg Tab
  • +5 more
  • Vancouver, British Columbia, Canada
  • +1 more
May 25, 2022

Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • San Francisco, California
    University of California San Francisco
Sep 20, 2022

Prostate Cancer Trial in Worldwide (Abiraterone, Apitolisib, Ipatasertib)

Completed
  • Prostate Cancer
  • Scottsdale, Arizona
  • +58 more
Sep 7, 2022

Prostate Cancer Trial in Boston (Abiraterone, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Feb 8, 2021

Prostate Cancer Trial in New York (apalutamide, Everolimus)

Completed
  • Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 29, 2021

Salivary Glands Tumors Trial in Milan (Abiraterone acetate)

Completed
  • Salivary Glands Tumors
  • Abiraterone acetate
  • Milan, Lombardy, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Mar 1, 2021

Prostate Cancer Trial in Washington, Baltimore (Leuprolide Acetate, Docetaxel, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +1 more
Mar 29, 2022

Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Seattle (Abiraterone

Completed
Has Results
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Abiraterone Acetate
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 22, 2021

Prostate Cancer, Castrate Resistant Prostate Cancer Trial (Abiraterone Acetate, Sodium Selenite, Prednisone)

Withdrawn
  • Prostate Cancer
  • Castrate Resistant Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • (no location specified)
Aug 5, 2021

Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Prostate Cancer
  • Leuprolide acetate
  • +9 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2022

Prostate Cancer Trial in Seville (AA Reduced dose-normal diet (A), AA reduced dose-fat diet (B), AA normal dose-fasting

Completed
  • Prostate Cancer
  • AA Reduced dose-normal diet (A)
  • +2 more
  • Seville, Spain
    Hospital Universitario Virgen del Rocío
Jan 8, 2021

Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer Trial in Nanjing (ADT, Abiraterone Acetate,

Recruiting
  • Neoadjuvant Therapy
  • +3 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Aug 12, 2022

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston,

Active, not recruiting
  • Castration Levels of Testosterone
  • +4 more
  • Abiraterone Acetate
  • +6 more
  • Houston, Texas
  • +2 more
Feb 11, 2022

Prostate Cancer Trial in United States (Zytiga® (Abiraterone Acetate), SoluMatrix™ (Abiraterone Acetate))

Completed
Has Results
  • Prostate Cancer
  • Zytiga® (Abiraterone Acetate)
  • SoluMatrix™ (Abiraterone Acetate)
  • Laguna Hills, California
  • +16 more
Nov 19, 2021

High Risk Localised Prostate Carcinoma Trial in Cork, Dublin, Galway (Abiraterone acetate, Prednisolone)

Completed
  • High Risk Localised Prostate Carcinoma
  • Abiraterone acetate, Prednisolone
  • Cork, Ireland
  • +2 more
Feb 18, 2021

Metastatic Prostate Cancer Trial (abiraterone acetate with Methylprednisolone)

Completed
Has Results
  • Metastatic Prostate Cancer
  • abiraterone acetate with Methylprednisolone
  • (no location specified)
Nov 18, 2021

Urothelial Carcinoma, Bladder Cancer Trial in Houston (Abiraterone acetate, Durvalumab, Methotrexate)

Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Abiraterone acetate
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 2, 2022